The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Zofran Zydis 4 mg oral lyophilisate

4 milligram(s) Oral lyophilisate

PCO Manufacturing Ltd.PPA0465/445/001

Main Information

Trade NameZofran Zydis 4 mg oral lyophilisate
Active SubstancesOndansetron
Strength4 milligram(s)
Dosage FormOral lyophilisate
Licence HolderPCO Manufacturing Ltd.
Licence NumberPPA0465/445/001

Group Information

ATC CodeA04AA Serotonin (5HT3) antagonists
A04AA01 ondansetron


Licence Issued31/05/2019
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back